01 May 2011: Public Health
Nosocomial infections and risk factors in the intensive care unit of a teaching and research hospital: A prospecive cohort study
Oznur Ak ABCDEF , Ayse Batırel BE , Serdar Ozer AB , Serhan Colakoglu B
DOI: 10.12659/MSM.881750
Med Sci Monit 2011; 17(5): PH29-34
Background
Nosocomial infections (NIs) constitute an important health problem with high incidence, morbidity and mortality rates worlwide. NIs have become particularly prominent in intensive care units (ICUs), where the incidence is 2 to 5 times higher than in the general hospitalized population [1]. Intensive care unit patients are at greater risk of developing NI because of several reasons including presence of underlying diseases, longer stay, invasive diagnostic and monitoring procedures performed, impaired host defences, and colonization by resistant microorganisms.
Determination of risk factors for developing infection in ICU patients is an important step for implementation of necessary precautions for prevention of infection. Initial empirical antimicrobial treatment should be targetted against the most likely local pathogens, when a NI is suspected. Therefore, the major concern of our study was the prospective assesment of the etiology and risk factors of NIs in the ICU of our hospital during a 1-year period.
Material and Methods
STATISTICAL ANALYSIS:
Statistical analysis was done with SPSS (Statistical Package for Social Sciences) software, version 10.0 (
Results
A total of 1134 patients were admitted to our ICU during the study period. The data collected in this study belonged to 450 patients who stayed >48 h in the ICU with 6257 patient-days during one year. Of the 450 patients, only 115 patients acquired nosocomial infections and the remaining 335 patients were non-infected. Of the 450 patients, aged between 6 months and 91 years, 267 (59.3.%) were male and 183 (40.7%) were female. The median age was 47.25±23.17 years. There were no significant differences in age and gender between patients with or without ICU-acquired nosocomial infections. Of the 450 patients, only 160 (35.5%) patients had one or more underlying diseases. The most frequent underlying diseases were neoplasia, neurological disease and chronic obstructive pulmonary disease. No significant difference was observed when infected and non-infected cases were compared in terms of underlying diseases (p=0.07). The most frequent causes of admission to ICU were respiratory failure (31.1%), trauma (24.7%) and neurologic disease (22.9%) (Table 1).
The APACHE-II scores ranged between 5 and 40, with a median of 20.46±5.6, with no significant difference between infected and non-infected patients (p=0.26)
Duration of stay in the ICU was between 3 and 165 days, with a median of 15.45±19.18 days in total study patients, 33.92±27.02 days in the infected patients, and 8.12±6.08 days in the non-infected patients. Longer ICU stay was a significant risk factor for development of NI (p=0.00).
A total of 135 nosocomial infections were detected in 115 (25.6%) of 450 patients. The incidence rate of nosocomial infections was 21.6 in 1000 patient-days, and the infection rate of nosocomial infections was 25.6%. The most frequent site of ICU-acquired NI in our study was the bloodstream (49, 36.3%), followed the respiratory system (41, 30.4%), the urinary tract (25, 18.5%), and catheter-related infection was diagnosed only in 10 patients, (7.4%). The distribution of isolated microorganisms by the sites of nosocomial infection is shown in Table 2. Of all nosocomial infections, 112 (83%) were microbiologically-confirmed (culture-positive) and 23 (17%) were clinically-defined (culture-negative) infections. The pathogens of the culture-confirmed nosocomial infections were Gram-negatives in 77 (68.8%), Gram-positives in 31 (27.6%), and fungi in 4 (3.6%). Among the 112 microorganisms, the most frequently isolated was
When the infected and non-infected patients were compared according to risk factors with univariate analysis, there was no significant difference with respect to age, gender, APACHE II scores, surgical history, presence of urinary and/or nasogastric catheters, or use of H2 receptor antagonists (p>0.05). Length of ICU stay, central venous catheterization, mechanical ventilation and tracheostomy were identified as statistically significant risk factors for developing nosocomial infection (p<0.05). Extrinsic risk factors in infected and non-infected patients are shown in Table 3.
Discussion
Assesment of infections acquired in ICUs, determination of their risk factors and establishment of correct treatment protocols are crucial steps in prevention and management of infections in ICUs. We planned this prospective surveillance study to determine the incidence, etiology and risk factors for NI in ICU patients at the Kartal Teaching and Research Hospital, Istanbul, Turkey.
In general, ICU-acquired infections constitute 20–25% of all hospital- acquired infections [4]. There may be variations in the incidence of ICU infections between centres, depending on the characteristics of patients and ICUs. In a point-prevalence study including 1417 centres in 17 European countries, the infection rate in ICUs was reported to be 20.6%. The infection rates in ICUs in several other studies reported by authors namely were as follows: Legras et al.: 21.6%, Appelgren et al.: 34%, Aly et al.: 10.6%, Ylipatosani et al.: 23.9%, and Urli et al.: 79% [5–10]. When we reviewed the rates of nosocomial infections reported in ICUs in our country, they differed from centre to centre. Meriç et al. reported the infection rate as 39.7%, Esen et al. (who reviewed the data of 56 ICUs in a 1-day point-prevelance study) as 48.7%, and Erbay et al. as 26% [11–13]. The hospital infection rate per 100 patient admissions in our hospital was calculated as 25.6%.
Certain specific risk factors play important roles in occurance of infections in ICUs. Several studies have determined the risk factors for ICU-acquired infections. Although some studies reported the patient age over 70 and the presence of underlying diseases to be a risk factor [6,14], the age and underlying diseases of the patients were not statistically significant risk factors for ICU-acquired infections in our study. A positive correlation between rates of nosocomial infections and average length of ICU stay have been reported in various studies [12,14–17]. In accordance with the results of these studies, length of ICU stay was a significant risk factor for ICU-acquired infection both in univariate and multivariate analyses in our study. Each invasive procedure performed poses a risk of infection. There was a direct correlation between central venous catheterization, tracheostomy, mechanical ventilation and the risk of infection in our study, in agreement with the results of other studies [7,11,14,18].
The most commonly reported sites of nosocomial infections in ICUs are the respiratory tract, followed by the urinary tract and the bloodstream, but the distribution of the sites and causes of infection may differ between centres. Table 4 shows the distribution of common NIs reported from ICU studies in various centres. In general, the most common type of infection in ICU is pneumonia, although Markogiannakis et al. reported bacteremia as the most commonly encountered ICU infection followed by pneumonia similar to the results in our study [8,11–13,16,17,19–21].
Our study revealed an unexpectedly higher frequency of BSI compared to other reports.
The higher occurrence of BSI seems to be closely related to specific and well-known risk factors such as the presence of indwelling venous catheters, and one or more critical underlying condition.
In majority of studies
In our study, the most common cause of ICU infections was
Conclusions
In conclusion, the bloodstream was the most common site of infection in our ICU. Central venous catheterization, mechanical ventilation, tracheostomy and longer stay in ICU were common risk factors for ICU-acquired infections. Etiologic agents, site and rate of ICU-acquired infections differ from centre to centre. Therefore, each hospital should define their own risk factors for infection, regularly conduct surveillence study of the infectious etiologies of NI, and establish prevention and treatment strategies accordingly, in order to improve the quality of health care.
References
1. Ewans TM, Ortiz CR, La Force FM, Prevention and control of nosocomial infection in the intensive care unit: Intensive Care Medicine, 1999; 1074-80, New York, Lippincott
2. Garner JS, Jarvis WR, Emori TG, CDC definitions for nosocomial infections: Am J Infect Control, 1988; 16; 128-40, pmid: 2841893
3. National Committee for Clinical Laboratory Standarts, Antimicrobial susceptibility tests: Approved Standard M100–S19, 2009, Wayne, PA, NCCLS
4. Trilla A, Epidemiology of nosocomial infections in adult intensive care units: Intensive Care Med, 1994; 20(Suppl 3); 1-4, pmid: 8163751
5. Vincent JL, Bihari DJ, Suter PM, The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee: JAMA, 1995; 274; 639-44, pmid: 7637145
6. Legras A, Malvy D, Quinioux AI, Nosocomial infections: prospective survey of incidence in five French intensive care units: Intensive Care Med, 1998; 24; 1040-46, pmid: 9840237
7. Appelgren P, Hellström I, Weitzberg E, Risk factors for nosocomial intensive care infection: a long-term prospective analysis: Acta Anaesthesiol Scand, 2001; 45; 710-19, pmid: 11421829
8. Aly NY, Al-Mousa HH, Al Asar el SM, Nosocomial Infections in a medical-surgical intensive care unit: Med Princ Pract, 2008; 17; 373-77, pmid: 18685276
9. Ylipalosaari P, Ala-Kokko TI, Laurila J, Intensive care acquired infection is an independent risk factor for hospital mortality: a prospective cohort study: Crit Care, 2006; 10; R66, pmid: 16626503
10. Urli T, Perone G, Acquarolo A, Surveillance of infections acquired in intensive care: usefulness in clinical practice: J Hosp Infect, 2002; 52; 130-35, pmid: 12392904
11. Meriç M, Wilke A, Çaglayan Ç, Toker K, Intensive care unit-acquired infections: Incidence, risk factors and associated mortality in a Turkish university hospital: Jpn J Infect Dis, 2005; 58; 297-302, pmid: 16249625
12. Esen S, Leblebicioglu H, Prevalence of nosocomial infections at intensive care units in Turkey: a multicentre 1-day point prevalence study: Scand J Infect Dis, 2004; 36; 144-48, pmid: 15061671
13. Erbay H, Yalçin AN, Serin S, Nosocomial infections in intensive care unit in a Turkish university hospital: a 2-year survey: Intensive Care Med, 2003; 29; 1482-88, pmid: 12898002
14. Craven DE, Kunches LM, Lichtenberg DA, Nosocomial infection and fatality in medical and surgical intensive care unit patients: Arch Intern Med, 1988; 148; 1161-68, pmid: 3365084
15. Ponce de León-Rosales SP, Molinar-Ramos F, Domínguez-Cherit G, Prevalence of infections in intensive care units in Mexico: a multicenter study: Crit Care Med, 2000; 28; 1316-21, pmid: 10834672
16. Vincent JL, Nosocomial infections in adult intensive care units: Lancet, 2003; 361; 2068-77, pmid: 12814731
17. Richards MJ, Edwards JR, Culver DH, Gaynes RP, Nosocomial infections in medical intensive care units in United States: National Nosocomial Infections Surveillance System: Crit Care Med, 1999; 27; 887-92, pmid: 10362409
18. Tennant I, Harding H, Nelson M, Roye-Green K, Microbial isolates from patients in an intensive care unit, and associated risk factors: West Indian Med J, 2005; 54; 225-31, pmid: 16312187
19. Richards MJ, Edwards JR, Culver DH, Gaynes RP, Nosocomial infections in combined medical–surgical intensive care units in the United States: Infect Control Hosp Epidemiol, 2000; 21; 510-15, pmid: 10968716
20. Kallel H, Dammak H, Bahloul M, Risk factors and outcomes of intensive care unit-acquired infections: in a Tunisian ICU Med Sci Monit, 2010; 16(8); PH69-75
21. Markogiannakis H, Pachylaki N, Samara E, Infections in a surgical intensive care unit of a university hospital in Greece: Int J Infect Dis, 2009; 13; 145-53, pmid: 18775663
In Press
Clinical Research
Institutional and Regional Variations in Access to Clinical Trials and Next-Generation Sequencing in Turkis...Med Sci Monit In Press; DOI: 10.12659/MSM.951027
Clinical Research
Low-Intensity Blood Flow-Restricted Multi-Joint Exercise Improves Muscle Function in Patients With Patellof...Med Sci Monit In Press; DOI: 10.12659/MSM.950516
Review article
Musculoskeletal Ultrasound and MRI in the Evaluation of Chemotherapy-Induced Peripheral Neuropathy: A ReviewMed Sci Monit In Press; DOI: 10.12659/MSM.951283
Clinical Research
Sensory Processing, Dissociation, and Affective Symptoms in Misophonia: A Cross-Sectional Study of 35 AdultsMed Sci Monit In Press; DOI: 10.12659/MSM.950938
Most Viewed Current Articles
17 Jan 2024 : Review article 10,187,196
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
13 Nov 2021 : Clinical Research 3,708,487
Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...DOI :10.12659/MSM.932788
Med Sci Monit 2021; 27:e932788
14 Dec 2022 : Clinical Research 2,341,643
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research 706,524
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387






